Detalhe da pesquisa
1.
GC-072: A Novel Therapeutic Candidate for Oral Treatment of Melioidosis and Infections Caused by Select Biothreat Pathogens.
Antimicrob Agents Chemother
; 63(12)2019 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31548183
2.
Molecular determinants of Burkholderia pseudomallei BpeEF-OprC efflux pump expression.
Microbiology (Reading)
; 164(9): 1156-1167, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30024368
3.
Antibiotic Resistance Markers in Burkholderia pseudomallei Strain Bp1651 Identified by Genome Sequence Analysis.
Antimicrob Agents Chemother
; 61(6)2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28396541
4.
Non-replicative phage particles delivering CRISPR-Cas9 to target major blaCTX-M variants.
PLoS One
; 19(5): e0303555, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38753729
5.
Burkholderia pseudomallei acquired ceftazidime resistance due to gene duplication and amplification.
Int J Antimicrob Agents
; 53(5): 582-588, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30639528
6.
Effective screening for double heterozygosity of Hb E/alpha0-thalassemia.
Ann Hematol
; 87(11): 911-4, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18575861
7.
Outer Membrane Vesicle Vaccines from Biosafe Surrogates Prevent Acute Lethal Glanders in Mice.
Vaccines (Basel)
; 6(1)2018 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29320408
8.
Transcriptional and post-transcriptional regulation of PenA ß-lactamase in acquired Burkholderia pseudomallei ß-lactam resistance.
Sci Rep
; 8(1): 10652, 2018 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30006637
9.
Mechanisms of Resistance to Folate Pathway Inhibitors in Burkholderia pseudomallei: Deviation from the Norm.
mBio
; 8(5)2017 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28874476
10.
Characterization of BPSS1521 (bprD), a regulator of Burkholderia pseudomallei virulence gene expression in the mouse model.
PLoS One
; 9(8): e104313, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25111708